| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 495 |
| 1 | RITUXIMAB | 407 |
| 2 | CYCLOPHOSPHAMIDE | 128 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 128 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 128 |
| 5 | DALFAMPRIDINE | 110 |
| 6 | OFATUMUMAB | 95 |
| 7 | PREDNISONE | 94 |
| 8 | METHYLPREDNISOLONE | 81 |
| 9 | MYCOPHENOLATE MOFETIL | 81 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PASSIFLORA INCARNATA, IGNATIA AMARA, VALERIANA OFFICINALIS | 1 | 0.0833 |
| 1 | FRANKINCENSE | 1 | 0.0169 |
| 2 | OCRELIZUMAB | 495 | 0.0080 |
| 3 | CLEMASTINE FUMARATE | 7 | 0.0052 |
| 4 | EPINASTINE HYDROCHLORIDE | 5 | 0.0044 |
| 5 | LANOLIN, PETROLATUM | 1 | 0.0041 |
| 6 | UBLITUXIMAB | 15 | 0.0040 |
| 7 | LANOLIN AND PETROLATUM | 1 | 0.0038 |
| 8 | ESTRIOL | 6 | 0.0034 |
| 9 | VINBLASTINE SULFATE | 6 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 968 |
| 1 | Corticosteroid [EPC] | 301 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 142 |
| 3 | Alkylating Drug [EPC] | 134 |
| 4 | Potassium Channel Blocker [EPC] | 110 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 70 |
| 6 | Purine Antimetabolite [EPC] | 67 |
| 7 | Vitamin C [EPC] | 46 |
| 8 | Vitamin B12 [EPC] | 44 |
| 9 | Vitamin D [EPC] | 41 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 968 | 0.0031 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 33 | 0.0017 |
| 2 | Potassium Channel Blocker [EPC] | 110 | 0.0015 |
| 3 | Cannabinoid [EPC] | 12 | 0.0015 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 14 | 0.0010 |
| 5 | Complement 5a Receptor Antagonist [EPC] | 6 | 0.0009 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 70 | 0.0008 |
| 7 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |
| 8 | Purine Antimetabolite [EPC] | 67 | 0.0007 |
| 9 | Sympathomimetic-like Agent [EPC] | 20 | 0.0006 |